332023-12-8 Usage
General Description
1-(2-chloro-6-nitrophenyl)piperazine is a chemical compound with a molecular formula C10H13ClN4O2. It is a piperazine derivative with a chloro and nitro group attached to the benzene ring. 1-(2-CHLORO-6-NITROPHENYL)PIPERAZINE is commonly used as an intermediate in the synthesis of various pharmaceuticals and organic compounds. It has potential applications in the development of psychiatric medications as it is known to have affinity for certain neurotransmitter receptors in the brain. Additionally, it is also used in the research and development of new drugs for treating neurological disorders and mental health conditions. Its chemical properties and structural features make it an important building block for the synthesis of a wide range of biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 332023-12-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,2,0,2 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 332023-12:
(8*3)+(7*3)+(6*2)+(5*0)+(4*2)+(3*3)+(2*1)+(1*2)=78
78 % 10 = 8
So 332023-12-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H12ClN3O2/c11-8-2-1-3-9(14(15)16)10(8)13-6-4-12-5-7-13/h1-3,12H,4-7H2
332023-12-8Relevant articles and documents
Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors
Shin, Youseung,Chen, Weiming,Habel, Jeff,Duckett, Derek,Ling, Yuan Yuan,Koenig, Marcel,He, Yuanjun,Vojkovsky, Tomas,LoGrasso, Philip,Kamenecka, Theodore M.
scheme or table, p. 3344 - 3347 (2010/03/03)
A novel series of c-jun N-terminal kinase (JNK) inhibitors were designed and developed from a high-throughput-screening hit. Through the optimization of the piperazine amide 1, several potent compounds were discovered. The X-ray crystal structure of 4g sh
Method for treating allergies using substituted pyrazoles
-
, (2008/06/13)
A method for treating an allergic condition, including an atopic allergic condition, using substituted pyrazoles.